Participant flow

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) · Source last updated 2022-10-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   CSF prescribing for patients taking anti-cancer drugs is based on existing automated system recommendations: CSF is recommended for drugs with high risk of FN; CSF is not recommended for drugs with low risk of FN. Preventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies

   id

   FG000

   title

   Active Comparator: Clinic Group 1 (Clinics With Existing Automated System for CSF Prescribing)

2. description

   CSF prescribing for patients taking anti-cancer drugs is based on existing clinical practice guidelines. Preventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies

   id

   FG001

   title

   Active Comparator: Clinic Group 2 (Clinics With no Automated System for CSF Prescribing)

3. description

   CSF prescribing for patients taking anti-cancer drugs is based on automated system recommendations: CSF is recommended for drugs with intermediate or high risk of FN; CSF is not recommended for drugs with low risk of FN. Preventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies

   id

   FG002

   title

   Experimental: Clinic Group 3 (Clinics With Automated System for CSF Prescribing)

4. description

   CSF prescribing for patients taking anti-cancer drugs is based on automated system recommendations: CSF is recommended for drug with high risk of FN; CSF is not recommended for drugs with intermediate or low risk of FN. Preventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies

   id

   FG003

   title

   Experimental: Clinic Group 4 (Clinics With Automated System for CSF Prescribing)

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         6

      3. group Id

         FG002

         num Subjects

         7

      4. group Id

         FG003

         num Subjects

         7

      type

      Refusal unrelated to adverse event

   2. reasons

      1. group Id

         FG000

         num Subjects

         44

      2. group Id

         FG001

         num Subjects

         42

      3. group Id

         FG002

         num Subjects

         123

      4. group Id

         FG003

         num Subjects

         68

      type

      Death

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         707

      2. group Id

         FG001

         num Subjects

         644

      3. group Id

         FG002

         num Subjects

         1281

      4. group Id

         FG003

         num Subjects

         973

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         665

      2. group Id

         FG001

         num Subjects

         602

      3. group Id

         FG002

         num Subjects

         1158

      4. group Id

         FG003

         num Subjects

         905

      type

      Treatment Completed

   3. achievements

      1. group Id

         FG000

         num Subjects

         660

      2. group Id

         FG001

         num Subjects

         596

      3. group Id

         FG002

         num Subjects

         1151

      4. group Id

         FG003

         num Subjects

         898

      type

      COMPLETED

   4. achievements

      1. group Id

         FG000

         num Subjects

         47

      2. group Id

         FG001

         num Subjects

         48

      3. group Id

         FG002

         num Subjects

         130

      4. group Id

         FG003

         num Subjects

         75

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice